Skip to main content
About Us > Jerome D. Hamilton, Jr.

Jerome D. Hamilton, Jr.

Chief Business Officer

Jerome D. Hamilton, Jr. is Chief Business Officer (CBO) of Open Therapeutics. In this role, he is able to spend more focused time to follow his passion of educating both the scientific and investment community on the importance of scientific collaboration free of constraints.  He also enjoys excelling in articulating the strategic plan and value proposition of Open Therapeutics, particularly the Company’s exciting blockchain integration into open science.

Prior to his role as CBO, he was the CEO of Open Therapeutics.  He built the Company’s investor base and led strategic partnerships and oversaw team formation.  Under his leadership, the Therapoid platform moved from prototype to alpha version.

Prior to Open Therapeutics, Jerome was the Senior Vice President of Global Operations at Stratasys where he focused on ensuring Global Operations supported aggressive corporate growth from both a strategic and tactical perspective. Prior to Stratasys, he was Vice President at 3M where he devised strategic and operational plans for 3M’s Industrial Business Group. He was also the leader of the company’s Masking and Surface Protection Business with full P&L responsibilities. Hamilton also has extensive experience in Lean Six Sigma Operations, Corporate Quality and Acquisition Integration.  Prior to 3M, he was plant manager at Ford Motor Company where he reversed declining productivity at one facility, making it the top-ranked plant among twenty Ford plants.

Hamilton earned his Bachelor of General Science from Morehouse College, a Bachelor of Science in Industrial Engineering from Georgia Tech, and a Master of Science in Engineering Management from the University of Detroit Mercy. He also holds a Master of Science in International Logistics from Georgia Tech and has completed the Harvard Business School’s Advanced Management Program.

Our Effort

Open Therapeutics is a major backer of open science and open access efforts.

Open Therapeutics freely provides to science, technology, engineering, and math (STEM) scientists, or another other seriously interested persons, intellectual properties (patents, etc.), grant funding, lab equipment, document development tools, and preprint server in a collaboration platform (Therapoid™).

When the researchers advance the intellectual properties, s/he gains ScienceCoins™; a blockchain-based cryptocurrency.